In a recent achievement, DP Technology's hit discovery platform RiDYMO® has successfully designed a cyclic peptide targeting β-catenin, a historically 'undruggable' protein, in just two months. This ...
Umbrella Labs has expanded its range of compounds, providing a wider selection of refined options to support research across various scientific fields. This increased variety includes ...
MessageGears, the leading data activation and engagement platform for enterprises, today shared the trends it predicts will have the most impact on consumer brands in 2025: Marketing and IT teams will ...
Nuvie Bio, a new clinical-stage biopharmaceutical company dedicated to addressing the most pressing unmet medical needs in migraine and related neurological diseases, announced completion of a ...
Study to Evaluate the Safety and Efficacy of Oral VK2735 Dosed Once Daily. SAN DIEGO, CA, USA I January 8, 2025 I Viking Therapeutics, Inc. (“Viking”) (NASDAQ: VKTX), ...